Published in Neuroscience on January 01, 2005
Mucosal immunization with an attenuated Salmonella vaccine partially protects white-tailed deer from chronic wasting disease. Vaccine (2014) 2.10
Active and passive immunotherapy for neurodegenerative disorders. Annu Rev Neurosci (2008) 2.01
Clearance and prevention of prion infection in cell culture by anti-PrP antibodies. Eur J Neurosci (2006) 1.22
Immunomodulation targeting abnormal protein conformation reduces pathology in a mouse model of Alzheimer's disease. PLoS One (2010) 1.07
M cell-depletion blocks oral prion disease pathogenesis. Mucosal Immunol (2012) 1.03
Anti-PrP Mab 6D11 suppresses PrP(Sc) replication in prion infected myeloid precursor line FDC-P1/22L and in the lymphoreticular system in vivo. Neurobiol Dis (2009) 1.00
High titers of mucosal and systemic anti-PrP antibodies abrogate oral prion infection in mucosal-vaccinated mice. Neuroscience (2008) 0.98
Cross currents in protein misfolding disorders: interactions and therapy. CNS Neurol Disord Drug Targets (2009) 0.98
An oral recombinant vaccine in dogs against Echinococcus granulosus, the causative agent of human hydatid disease: a pilot study. PLoS Negl Trop Dis (2008) 0.94
DNA vaccination can break immunological tolerance to PrP in wild-type mice and attenuates prion disease after intracerebral challenge. J Virol (2006) 0.88
Novel aspects of prions, their receptor molecules, and innovative approaches for TSE therapy. Cell Mol Neurobiol (2006) 0.85
Effect of transplantation of bone marrow-derived mesenchymal stem cells on mice infected with prions. J Virol (2009) 0.83
Small-molecule theranostic probes: a promising future in neurodegenerative diseases. Int J Cell Biol (2013) 0.82
Salmonella enterica serovar Typhimurium immunotherapy for B-cell lymphoma induces broad anti-tumour immunity with therapeutic effect. Immunology (2014) 0.81
Immunomodulation for prion and prion-related diseases. Expert Rev Vaccines (2010) 0.80
Detection and control of prion diseases in food animals. ISRN Vet Sci (2012) 0.80
Could immunomodulation be used to prevent prion diseases? Expert Rev Anti Infect Ther (2012) 0.80
Diminished amyloid-beta burden in Tg2576 mice following a prophylactic oral immunization with a salmonella-based amyloid-beta derivative vaccine. J Alzheimers Dis (2009) 0.80
Immunization with recombinant prion protein leads to partial protection in a murine model of TSEs through a novel mechanism. PLoS One (2013) 0.79
A camelid anti-PrP antibody abrogates PrP replication in prion-permissive neuroblastoma cell lines. PLoS One (2010) 0.79
Dendritic cell-mediated-immunization with xenogenic PrP and adenoviral vectors breaks tolerance and prolongs mice survival against experimental scrapie. PLoS One (2009) 0.78
Prion protein-specific antibodies-development, modes of action and therapeutics application. Viruses (2014) 0.78
Mechanistic insights into the cure of prion disease by novel antiprion compounds. J Virol (2007) 0.77
The Priority position paper: Protecting Europe's food chain from prions. Prion (2016) 0.75
Neoadjuvant administration of Semliki Forest virus expressing interleukin-12 combined with attenuated Salmonella eradicates breast cancer metastasis and achieves long-term survival in immunocompetent mice. BMC Cancer (2015) 0.75
Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol (1987) 7.05
Helper T cell differentiation is controlled by the cell cycle. Immunity (1998) 5.71
Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. Am J Psychiatry (2000) 4.87
Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy. Nat Med (1998) 4.17
Mutations in familial Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker's syndrome. Exp Neurol (1989) 3.00
Trehalose expression confers desiccation tolerance on human cells. Nat Biotechnol (2000) 2.98
Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major. J Exp Med (1997) 2.81
Molecular assessment of the potential transmissibilities of BSE and scrapie to humans. Nature (1997) 2.80
Patterns and correlates of physical activity among US women 40 years and older. Am J Public Health (2000) 2.79
Salmonella: immune responses and vaccines. Vet J (2001) 2.68
The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex. Biochem J (1993) 2.66
Promoting physical activity in rural communities: walking trail access, use, and effects. Am J Prev Med (2000) 2.65
Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans. Transfusion (2000) 2.52
Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. Neurobiol Dis (1996) 2.50
Nicotine-induced limbic cortical activation in the human brain: a functional MRI study. Am J Psychiatry (1998) 2.40
Improved phylogenomic taxon sampling noticeably affects nonbilaterian relationships. Mol Biol Evol (2010) 2.39
Psychological monitoring of overtraining and staleness. Br J Sports Med (1987) 2.33
Reliability of information on physical activity and other chronic disease risk factors among US women aged 40 years or older. Am J Epidemiol (1999) 1.97
Replacement of bovine mitochondrial DNA by a sequence variant within one generation. Genetics (1991) 1.96
Immunological comparison of scrapie-associated fibrils isolated from animals infected with four different scrapie strains. J Virol (1986) 1.95
Case volume and outcome of endoscopic retrograde cholangiopancreatography: results of a nationwide Austrian benchmarking project. Endoscopy (2008) 1.91
European Society of Gastrointestinal Endoscopy, European Society of Gastroenterology and Endoscopy Nurses and Associates, and the European Society of Anaesthesiology Guideline: Non-anaesthesiologist administration of propofol for GI endoscopy. Eur J Anaesthesiol (2010) 1.87
In vitro replication of scrapie agent in a neuronal model: infection of PC12 cells. J Gen Virol (1984) 1.80
Determination of nitrite/nitrate in human biological material by the simple Griess reaction. Clin Chim Acta (1998) 1.77
Biochemical differences among scrapie-associated fibrils support the biological diversity of scrapie agents. J Gen Virol (1985) 1.75
Isolation of a cDNA clone encoding the leader peptide of prion protein and expression of the homologous gene in various tissues. Proc Natl Acad Sci U S A (1986) 1.75
Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E. Biochem J (1995) 1.72
Cloning of the filamentous hemagglutinin of Bordetella pertussis and its expression in Escherichia coli. Infect Immun (1987) 1.69
Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice. Am J Pathol (2001) 1.69
Detection of scrapie-associated fibril (SAF) proteins using anti-SAF antibody in non-purified tissue preparations. J Gen Virol (1986) 1.67
Effect of interleukin 12 neutralization on host resistance and gamma interferon production in mouse typhoid. Infect Immun (1996) 1.66
Infected splenic dendritic cells are sufficient for prion transmission to the CNS in mouse scrapie. J Clin Invest (2001) 1.66
Identification of a chromosomal determinant of alpha-toxin production in Staphylococcus aureus. Infect Immun (1980) 1.65
Intraoperative ventilator settings and acute lung injury after elective surgery: a nested case control study. Thorax (2008) 1.64
Protective vaccination with a recombinant fragment of Clostridium botulinum neurotoxin serotype A expressed from a synthetic gene in Escherichia coli. Infect Immun (1995) 1.61
Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid beta. Biochem Biophys Res Commun (1994) 1.60
Breath hydrogen excretion as a screening test for the early diagnosis of necrotizing enterocolitis. Am J Dis Child (1989) 1.58
An endogenous retrovirus and exogenous scrapie in a mouse model of aging. Trends Microbiol (2000) 1.57
Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. J Clin Invest (1994) 1.54
Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides. Lancet (2000) 1.54
Impact on process of trauma care delivery 1 year after the introduction of a trauma program in a provincial trauma center. J Trauma (1999) 1.52
Pituitary hemorrhage into a Rathke's cleft cyst. Neurosurgery (1990) 1.52
Effect of leptin deficiency on metabolic rate in ob/ob mice. Am J Physiol (1999) 1.51
Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients. Neuroscience (2003) 1.51
An improved in vitro pyrogen test: to detect picograms of endotoxin contamination in intravenous fluids using limulus amoebocyte lysate. J Lab Clin Med (1977) 1.50
Iatrogenic Creutzfeldt-Jakob disease: an example of the interplay between ancient genes and modern medicine. Neurology (1994) 1.50
Pall leukotrap affinity prion-reduction filter removes exogenous infectious prions and endogenous infectivity from red cell concentrates. Vox Sang (2006) 1.50
Role of microglia in neuronal cell death in prion disease. Brain Pathol (1998) 1.49
A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins. Transfusion (2001) 1.49
Creutzfeldt-Jacob disease associated with the PRNP codon 200Lys mutation: an analysis of 45 families. Eur J Epidemiol (1991) 1.48
Accumulation of alpha B-crystallin in central nervous system glia and neurons in pathologic conditions. Am J Pathol (1992) 1.46
Hand-held portable sonography for the on-mountain exclusion of a pneumothorax. Wilderness Environ Med (2001) 1.43
Mouse model of sublethal and lethal intraperitoneal glanders (Burkholderia mallei). Vet Pathol (2000) 1.43
Sequence determination of human papillomavirus type 6a and assembly of virus-like particles in Saccharomyces cerevisiae. Virology (1995) 1.43
Analysis of bacteriophage phi X174 gene A protein-mediated termination and reinitiation of phi X DNA synthesis. II. Structural characterization of the covalent phi X A protein-DNA complex. J Biol Chem (1984) 1.41
A multicomponent program for nutrition and physical activity change in primary care: PACE+ for adolescents. Arch Pediatr Adolesc Med (2001) 1.40
Trichostatin A reverses skewed expression of CD154, interleukin-10, and interferon-gamma gene and protein expression in lupus T cells. Proc Natl Acad Sci U S A (2001) 1.39
Cephalexin-supplemented Jones-Kendrick charcoal agar for selective isolation of Bordetella pertussis: comparison with previously described media. J Clin Microbiol (1983) 1.37
Transcriptional activation of the human epidermal growth factor receptor promoter by human p53. Mol Cell Biol (1996) 1.37
Amyloid beta binding proteins in vitro and in normal human cerebrospinal fluid. Neurosci Lett (1995) 1.36
Antisera to scrapie-associated fibril protein and prion protein decorate scrapie-associated fibrils. J Virol (1987) 1.35
Aberrant metal binding by prion protein in human prion disease. J Neurochem (2001) 1.33
The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice. Neurobiol Aging (2001) 1.31
Neutralization of human papillomavirus (HPV) pseudovirions: a novel and efficient approach to detect and characterize HPV neutralizing antibodies. Virology (2000) 1.31
Oxidative impairment in scrapie-infected mice is associated with brain metals perturbations and altered antioxidant activities. J Neurochem (2001) 1.30
Serodiagnosis of leprosy: relationships between antibodies to Mycobacterium leprae phenolic glycolipid I and protein antigens. J Clin Microbiol (1986) 1.28
Perceived barriers to exercise and stage of exercise adoption in older women of different racial/ethnic groups. Women Health (2000) 1.28
CEREBELLAR ABSCESSES OF OTITIC ORIGIN IN NINE CHILDREN: EIGHT RECOVERIES AFTER CANNULATION. Ann Surg (1941) 1.28
The use of quaternary narcotic antagonists in opiate research. Neuropharmacology (1985) 1.27
Clinical versus subclinical pituitary apoplexy: presentation, surgical management, and outcome in 21 patients. Neurosurgery (1990) 1.27
Support for policy interventions to increase physical activity in rural Missouri. Am J Health Promot (1998) 1.26
The human gastrin/cholecystokinin type B receptor gene: alternative splice donor site in exon 4 generates two variant mRNAs. Proc Natl Acad Sci U S A (1993) 1.26
Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women. J Med Virol (2007) 1.23
Limits in reliability of glycoprotein G-based type-specific serologic assays for herpes simplex virus types 1 and 2. J Clin Microbiol (1999) 1.22
Human papillomavirus type 11 (HPV-11) neutralizing antibodies in the serum and genital mucosal secretions of African green monkeys immunized with HPV-11 virus-like particles expressed in yeast. J Infect Dis (1997) 1.20
Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia. J Med Virol (2001) 1.20
Immunohistochemical detection of prion protein in sheep with scrapie. J Vet Diagn Invest (1993) 1.20
28-day survival rates of 6676 neonates with birth weights of 1250 grams or less. Pediatrics (1991) 1.19
Use of sedation for routine diagnostic upper gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy Survey of National Endoscopy Society Members. Digestion (2006) 1.19
Wild-type human p53 activates the human epidermal growth factor receptor promoter. Oncogene (1994) 1.16
Screening for lead poisoning in an urban pediatric clinic using samples obtained by fingerstick. Pediatrics (1994) 1.15
The interaction between apolipoprotein E and Alzheimer's amyloid beta-peptide is dependent on beta-peptide conformation. J Biol Chem (1996) 1.14
The hamster model of intraperitoneal Burkholderia mallei (glanders). Vet Pathol (1999) 1.14
Longitudinal cerebrospinal fluid tau load increases in mild cognitive impairment. Neurosci Lett (2002) 1.14
Conformation as therapeutic target in the prionoses and other neurodegenerative conditions. Methods Mol Med (2001) 1.12
Transmission of human papillomavirus type 11 infection by desquamated cornified cells. Virology (2001) 1.12
Atypical keloids after dermabrasion of patients taking isotretinoin. J Am Acad Dermatol (1986) 1.12
Mycobacterial carbohydrate antigens for serological testing of patients with leprosy. J Infect Dis (1987) 1.12
Regulation of cytokine production during development of autoimmune diabetes induced with multiple low doses of streptozotocin. J Immunol (1996) 1.11
Mites as vectors for scrapie. Lancet (1996) 1.11
Clinical studies with recombinant-DNA-derived methionyl human growth hormone in growth hormone deficient children. Lancet (1986) 1.10
Localization of CB1-cannabinoid receptor immunoreactivity in the porcine enteric nervous system. Cell Tissue Res (2000) 1.10
Liposuction for lipomas. J Dermatol Surg Oncol (1985) 1.10
Predictors of adopting leisure-time physical activity among a biracial community cohort. Am J Epidemiol (1995) 1.09
Association of herpesvirus with fibropapillomatosis of the green turtle Chelonia mydas and the loggerhead turtle Caretta caretta in Florida. Dis Aquat Organ (1999) 1.09
N-terminal 130 amino acids of MDM2 are sufficient to inhibit p53-mediated transcriptional activation. Oncogene (1995) 1.08